全文获取类型
收费全文 | 26260篇 |
免费 | 1791篇 |
国内免费 | 99篇 |
专业分类
耳鼻咽喉 | 253篇 |
儿科学 | 490篇 |
妇产科学 | 494篇 |
基础医学 | 4002篇 |
口腔科学 | 523篇 |
临床医学 | 2690篇 |
内科学 | 5716篇 |
皮肤病学 | 447篇 |
神经病学 | 2395篇 |
特种医学 | 1231篇 |
外科学 | 4228篇 |
综合类 | 187篇 |
一般理论 | 4篇 |
预防医学 | 1522篇 |
眼科学 | 456篇 |
药学 | 1859篇 |
中国医学 | 27篇 |
肿瘤学 | 1626篇 |
出版年
2023年 | 200篇 |
2022年 | 237篇 |
2021年 | 488篇 |
2020年 | 398篇 |
2019年 | 549篇 |
2018年 | 643篇 |
2017年 | 576篇 |
2016年 | 617篇 |
2015年 | 692篇 |
2014年 | 860篇 |
2013年 | 1204篇 |
2012年 | 1713篇 |
2011年 | 1702篇 |
2010年 | 945篇 |
2009年 | 905篇 |
2008年 | 1500篇 |
2007年 | 1535篇 |
2006年 | 1454篇 |
2005年 | 1319篇 |
2004年 | 1191篇 |
2003年 | 1108篇 |
2002年 | 1036篇 |
2001年 | 506篇 |
2000年 | 461篇 |
1999年 | 458篇 |
1998年 | 278篇 |
1997年 | 217篇 |
1996年 | 220篇 |
1995年 | 165篇 |
1994年 | 187篇 |
1993年 | 171篇 |
1992年 | 336篇 |
1991年 | 321篇 |
1990年 | 350篇 |
1989年 | 347篇 |
1988年 | 330篇 |
1987年 | 279篇 |
1986年 | 273篇 |
1985年 | 290篇 |
1984年 | 224篇 |
1983年 | 210篇 |
1982年 | 136篇 |
1981年 | 119篇 |
1980年 | 90篇 |
1979年 | 141篇 |
1978年 | 112篇 |
1977年 | 86篇 |
1975年 | 94篇 |
1974年 | 116篇 |
1973年 | 104篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
991.
Salmon Mandy K Hammer Karen Eich Nygaard Jens Vinge Korsholm Kasper Johansen Peter Nielsen-Kudsk Jens Erik 《Journal of interventional cardiac electrophysiology》2021,61(1):207-208
Journal of Interventional Cardiac Electrophysiology - For Fig. 4, an internal working draft of the image depicting the device placed in the heart was erroneously provided during the... 相似文献
992.
Rune E. Kuhre PhD Carolyn F. Deacon DMSci Nicolai J. Wewer Albrechtsen PhD Jens J. Holst DMSci 《Diabetes, obesity & metabolism》2021,23(9):2009-2019
Sodium-glucose co-transporter-2 inhibitors (SGLT2is) lower blood glucose and are used for treatment of type 2 diabetes. However, SGLT2is have been associated with increases in endogenous glucose production (EGP) by mechanisms that have been proposed to result from SGLT2i-mediated increases in circulating glucagon concentrations, but the relative importance of this effect is debated, and mechanisms possibly coupling SGLT2is to increased plasma glucagon are unclear. A direct effect on alpha-cell activity has been proposed, but data on alpha-cell SGLT2 expression are inconsistent, and studies investigating the direct effects of SGLT2 inhibition on glucagon secretion are conflicting. By contrast, alpha-cell sodium-glucose co-transporter-1 (SGLT1) expression has been found more consistently and appears to be more prominent, pointing to an underappreciated role for this transporter. Nevertheless, the selectivity of most SGLT2is does not support interference with SGLT1 during therapy. Paracrine effects mediated by secretion of glucagonotropic/static molecules from beta and/or delta cells have also been suggested to be involved in SGLT2i-induced increase in plasma glucagon, but studies are few and arrive at different conclusions. It is also possible that the effect on glucagon is secondary to drug-induced increases in urinary glucose excretion and lowering of blood glucose, as shown in experiments with glucose clamping where SGLT2i-associated increases in plasma glucagon are prevented. However, regardless of the mechanisms involved, the current balance of evidence does not support that SGLT2 plays a crucial role for alpha-cell physiology or that SGLT2i-induced glucagon secretion is important for the associated increased EGP, particularly because the increase in EGP occurs before any rise in plasma glucagon. 相似文献
993.
Kim K. B. Clemmensen MD Martin B. Blond PhD Hanan Amadid PhD Lea Bruhn MSc Dorte Vistisen PhD Kristian Karstoft PhD Frederik Persson DMSc Mathias Ried-Larsen PhD Jens J. Holst DMSc Nicolai J. Wewer Albrechtsen PhD Signe S. Torekov PhD Jonas S. Quist PhD Marit E. Jørgensen PhD Kristine Færch PhD 《Diabetes, obesity & metabolism》2021,23(2):530-539
994.
995.
Trond Engjom Ingrid Kvåle Nordaas Erling Tjora Georg Dimcevski Ingfrid Salvesen Haldorsen Søren Schou Olesen Asbjørn Mohr Drewes Kristina Zviniene Giedrus Barauskas Hans Søe Riis Jespersen Nanna Jensen Anders Borch Camilla Nøjgaard Srdan Novovic Svetlana S. Kardasheva Alexey Okhlobystin Truls Hauge Anne Waage Jens Brøndum Frøkjær 《Pancreatology》2021,21(4):688-697
ObjectivesThe relation between aetiology and structural changes of the pancreas in patients with chronic pancreatitis (CP) is not fully understood. Earlier studies are limited by focusing on selected factors in studies of limited sample size. We aimed to use a large dataset to explore associations between aetiology and pancreatic morphology in CP.MethodsSubjects with definite or probable CP according to the M-ANNHEIM diagnostic criteria were included in this multicentre cross-sectional observational study and assessed using a standardized and validated CP imaging system. We performed multivariate logistic regression to analyse if aetiological factors adjusted for covariates were independently associated with morphological pancreatic features.ResultsWe included 959 patients (66% males). Mean (SD) age was 55 (14) years. Pancreatic structural changes were found in 94% of the subjects: 67% had calcifications, 59% main pancreatic duct dilatation, 33% pseudo-cysts and 22% pancreatic atrophy. Alcohol abuse was independently associated with pancreatic calcifications (odds ratio (OR, [95% CI]); 1.61, [1.09, 2.37]) and focal acute pancreatitis (OR; 2.13, [1.27, 3.56]), whereas smoking was independently associated with more severe calcifications (OR; 2.09, [1.34, 3.27]) and involvement of the whole gland (OR; 2.29, [1.61, 3.28]). Disease duration was positively associated with calcifications (OR; (per year) 1.05 [1.02, 1.08]) and pancreatic atrophy (OR; 1.05 [1.02, 1.08]) and negatively associated with focal acute pancreatitis (OR 0.91, [0.87, 0.95] and pseudo cysts (OR; 0.96, [0.93, 0.98]).ConclusionIn this large-scale study, etiological risk factors and disease duration in CP were independently associated with specific structural pancreatic imaging changes. 相似文献
996.
997.
Liver steatosis is a common complication of chronic hepatitis C virus (HCV) infection, which can result in accelerated liver fibrosis development, especially in patients infected with genotype 3a. The precise mechanisms of HCV-induced liver steatosis remain unclear, but it is often posited that increased intracellular lipid accumulation is the underlying cause of steatosis. To study experimentally how HCV infection in human liver derived cells by different genotypes and subtypes might affect lipid accumulation, we performed detailed cytofluorimetric and microscopy analyses of intracellular lipid droplets (LDs) in relation to the viral Core and to cell endoplasmic reticulum proteins. Following culture infection with HCV genotype 1a, 2a, 2b, 2c, and 3a strains, we found variable levels of intracellular LDs accumulation, associated to the infecting strain rather than to the specific genotype. Although two genotype 3a strains showed high levels of lipid accumulation, as previously observed, some strains of other genotypes displayed a similar phenotype. Moreover, the analyses of LDs size, number, and shape indicated that the apparent increase in lipid accumulation is due to an increase in the overall number rather than in the size of droplets. Finally, differences in total lipid content across genotypes did not correlate to differences in Core distribution nor Core levels. In conclusion, our study provides a quantitative in-depth analysis of the effect of HCV infection on LDs accumulation in cell-culture. 相似文献
998.
999.
1000.